Diabetes-associated alterations in volatile anesthetic actions on contractile response to norepinephrine in isolated mesenteric resistance arteries

Anesthesiology

Volumn 112, Issue 3, 2010, Pages 595-606

  Yoshino, Jun ^a   Akata, Takashi ^a   Shirozu, Kazuhiro ^a   Izumi, Kaoru ^a   Hoka, Sumio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENOMEDULLIN; ANGIOTENSIN II; BARIUM; CALCITONIN GENE RELATED PEPTIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; GLYCYRRHETINIC ACID; INDOMETACIN; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETANSERIN; LOSARTAN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE; NORADRENALIN; OUABAIN; PROSTAGLANDIN SYNTHASE; SEROTONIN; SEVOFLURANE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG MECHANISM; GAP JUNCTION; MALE; MESENTERIC ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 77649122722     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181ce9e80     Document Type: Article

References (60)

1. Akata T: General anesthetics and vascular smooth muscle: Direct actions of general anesthetics on cellular mechanisms regulating vascular tone. ANESTHESIOLOGY 2007; 106: 365-391
2. Burgos LG, Ebert TJ, Asiddao C, Turner LA, Pattison CZ, Wang-Cheng R, Kampine JP: Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. ANESTHESIOLOGY 1989; 70:591-597
3. Ebert TJ: Physiology of the cardiovascular effects of general anesthesia in the elderly, syllabus on geriatric anesthesiology version 1/10/02. Am Soc Anesthesiol 2009:7-8
4. Busija DW, Miller AW, Katakam P, Simandle S, Erdos B: Mechanisms of vascular dysfunction in insulin resistance. Curr Opin Investig Drugs 2004; 5:929-935
5. Dandona P, Chaudhuri A, Aljada A: Endothelial dysfunction and hypertension in diabetes mellitus. Med Clin North Am 2004; 88:911-931 (Pubitemid 39090345)
6. Christ G, Wingard C: Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation. Curr Opin Investig Drugs 2005; 6:920-933
7. Salamanca DA, Khalil RA: Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol 2005; 70: 1537-1547
8. Schiffrin EL: Vascular endothelin in hypertension. Vascul Pharmacol 2005; 43:19-29
9. Jarajapu YP, Knot HJ: Relative contribution of rho kinase and protein kinase C to myogenic tone in rat cerebral arteries in hypertension. Am J Physiol 2005; 289: H1917-22
10. Matsumoto T, Wakabayashi K, Kobayashi T, Kamata K: Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery. Am J Physiol 2004; 287:H1064-71
11. Lu T, Wang X-L, He T, Zhou W, Kaduce TL, Katusic ZS, Spector AA, Lee H-C: Impaired arachidonic acid-mediated activation of large-conductance Ca2+-activated K+ channels in coronary arterial smooth muscle cells in Zucker diabetic fatty rats. Diabetes 2005; 54:2155-2163
12. Kamata K, Miyata N, Kasuya Y: Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 1989; 249:890-894
13. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130:963-974
14. Peter RB, Virginijus V, Hong-Zhan W, Weixin Z, Kelvin D, George JC: Experimental diabetes alters connexin43 derived gap junction permeability in short-term cultures of rat corporeal vascular smooth muscle cells. J Urol 2006; 175:381-386
15. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: A statement for healthcare professionals From the American Heart Association. Circulation 1999; 100:1134-1146
16. Little S, Jarnagin W, DeMatteo R, Blumgart L, Fong Y: Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002; 6:88-94
17. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH: Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40:418-423
18. Vohra A, Kumar S, Charlton AJ, Olukoga AO, Boulton AJM, McLeod D: Effect of diabetes mellitus on the cardiovascular responses to induction of anaesthesia and tracheal intubation. Br J Anaesth 1993; 71:258-261
19. Blaise G, Sill JC, Nugent M, Van Dyke RA, Vanhoutte PM: Isoflurane causes endothelium-dependent inhibition of contractile responses of canine coronary arteries. ANESTHE-SIOLOGY 1987; 67:513-517
20. Stone DJ, Johns RA: Endothelium-dependent effects of halothane, enflurane, and isoflurane on isolated rat aortic vascular rings. ANESTHESIOLOGY 1989; 71:126-132
21. Izumi K, Akata T, Takahashi S: The action of sevoflurane on vascular smooth muscle of isolated mesenteric resistance arteries (part 1): Role of endothelium. ANESTHESIOL-OGY 2000; 92:1426-1440
22. Izumi K, Akata T, Takahashi S: Role of endothelium in the action of isoflurane on vascular smooth muscle of isolated mesenteric resistance arteries. ANESTHESIOLOGY 2001; 95: 990-998 (Pubitemid 32939126)
23. Yoshino J, Akata T, Izumi K, Takahashi S: Multiple actions of halothane on contractile response to noradrenaline in isolated mesenteric resistance arteries. Naunyn Schmiede-bergs Arch Pharmacol 2005; 371:500-515
24. 2, but not nor-adrenaline, of aortae from rats with streptozotocin-in-duced diabetes mellitus. Br J Pharmacol 1991; 104:928-932
25. Agrawal DK, McNeill JH: Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol 1987; 65:1484-1490
26. Carmines PK, Ohishi K: Renal arteriolar contractile responses to angiotensin ii in rats with poorly controlled diabetes mellitus. Clin Exp Pharmacol Physiol 1999; 26: 877-882
27. Takenouchi Y, Kobayashi T, Matsumoto T, Kamata K: Possible involvement of Akt activity in endothelial dysfunction in type 2 diabetic mice. J Pharmacol Sci 2008; 106:600-608
28. Sheykhzade M, Dalsgaard GT, Johansen T, Nyborg NCB: The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: Selective attenuation of CGRP-induced relaxations. Br J Pharmacol 2000; 129:1212-1218
29. Oku H, Kodama T, Sakagami K, Puro DG: Diabetes-induced disruption of gap junction pathways within the retinal microvasculature. Invest Ophthalmol Vis Sci 2001; 42: 1915-1920
30. Tare M, Coleman HA, Parkington HC: Regulation of vascular smooth muscle relaxation by the endothelium in health and in diabetes (with a focus on endothelium-derived hyperpo-larizing factor). Neurophysiology 2003; 35:256-261
31. Akata T, Yoshitake J, Nakashima M, Itoh T: Effects of protamine on vascular smooth muscle of rabbit mesenteric artery. ANESTHESIOLOGY 1991; 75:833-846
32. Akata T, Boyle III WA: Volatile anesthetic actions on contractile proteins in membrane-permeabilized small mesen-teric arteries. ANESTHESIOLOGY 1995; 82:700-712
33. Akata T, Kodama K, Takahashi S: Volatile anaesthetic actions on norepinephrine-induced contraction of small splanchnic resistance arteries. Can J Anaesth 1995; 42: 1040-1050
34. Drummond JC: MAC for halothane, enflurane, and isoflu-rane in the New Zealand white rabbit: And a test for the validity of MAC determinations. ANESTHESIOLOGY 1985; 62: 336-338
35. Taheri S, Halsey MJ, Liu J, Eger EI II, Koblin DD, Laster MJ: What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991; 72:627-634
36. Yamazaki M, Stekiel TA, Bosnjak ZJ, Kampine JP, Stekiel WJ: Effects of volatile anesthetic agents on in situ vascular smooth muscle transmembrane potential in resistance-and capacitance-regulating blood vessels. ANESTHESIOLOGY 1998; 88:1085-1095
37. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A: Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993; 196: 245-251
38. Fujioka H, Okamura T, Toda N: Inhibition by adrenomedullin of amine release from adrenergic nerves in dog mesenteric arteries. Eur J Pharmacol 1999; 385:155-161
39. Yamamoto Y, Fukuta H, Nakahira Y, Suzuki H: Blockade by 18beta-glycyrrhetinic acid of intercellular electrical coupling in guinea-pig arterioles. J Physiol (Lond) 1998; 511(Pt 2):501-508
40. Santicioli P, Maggi CA: Effect of 18[beta]-glycyrrhetinic acid on electromechanical coupling in the guinea-pig renal pelvis and ureter. Br J Pharmacol 2000; 129:163-169
41. Nawate S, Fukao M, Sakuma I, Soma T, Nagai K, Takikawa O, Miwa S, Kitabatake A: Reciprocal changes in endothe-lium-derived hyperpolarizing factor-and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy. Br J Pharmacol 2005; 144:178-189
42. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH: K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396:269-272 (Pubitemid 28541391)
43. Luscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. Boca Raton, CRC press, 1990
44. Lacza Z, Dezsi L, Kaldi K, Horvath EM, Sandor P, Benyo Z: Prostacyclin-mediated compensatory mechanism in the coronary circulation during acute NO synthase blockade. Life Sci 2003; 73:1141-1149
45. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, Kaley G: In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol Heart Circ Physiol 2000; 278:H762-8
46. De Lean AP, Munson PJ, Rodbard D: Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978; 235:E97-102
47. Gilbert RE, Jasik M, DeLuise M, O'Callaghan CJ, Cooper ME: Diabetes and hypertension\Australian Diabetes Society position statement. Med J Australia 1995; 163:372-375
48. Dora KA, Hinton JM, Walker SD, Garland CJ: An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br J Pharmacol 2000; 129:381-387
49. Edwards RM, Trizna W, Aiyar N: Adrenomedulin: A new peptide involved in cardiorenal homeostasis. Exp Nephrol 1997; 5:18-22
50. Doi Y, Kudo H, Nishino T, Kayashima K, Kiyonaga H, Nagata T, Nara S, Morita M, Fujimoto S: Synthesis of calci-tonin gene-related peptide (CGRP) by rat arterial endothe-lial cells. Histol Histopathol 2001; 16:1073-1079
51. Yamamoto Y, Imaeda K, Suzuki H: Endothelium-depen-dent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles. J Physiol 1999; 514:505-513
52. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC: Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res 2002; 90:1108-1113 (Pubitemid 34627910)
53. Katusic ZS, Vanhoutte PM: Superoxide anion is an endo-thelium-derived contracting factor. Am J Physiol 1989; 257:H33-7
54. Barlow RS, White RE: Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol 1998; 275:H1283-9
55. Iida Y, Katusic ZS, Wei EP: Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 2000; 31:2224-2230
56. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000; 106:1521-1530
57. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Com-mun 2002; 290:909-913
58. Kirpichnikov D, Sowers JR: Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metabol 2001; 12:225-230
59. Klein R: Hyperglycemia and microvascular and macrovas-cular disease in diabetes. Diabetes Care 1995; 18:258-268
60. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut J-G, Arnoux D, Charpiot P, Freyssinet J-M, Oliver C, Sampol J, Dignat-George F: Type 1 and type 2 diabetic patients display different patterns of cellular micropar-ticles. Diabetes 2002; 51:2840-2845